As part of our ongoing effort to bring you reports of interesting new studies, we have added a study comparing fingolimod, dimethyl fumarate, and teriflunomide for multiple sclerosis.
Independent expert commentary is provided by Professor Richard Macdonell, Director of Neurology at Austin Health.
Please login below to download this issue (PDF)